Subcutaneous Semaglutide in Systemic Scleroderma

Clinical trial NCT06149260 · UNKNOWN

Trial details

NCT number: NCT06149260
Sponsor: Second Xiangya Hospital of Central South University
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Scleroderma, Systemic Fibrosis Semaglutide

Start date: 2024-02-29
Primary completion: 2024-08-29
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.